Journal article

Population access to new vaccines in European countries

Time from registration to population access to new vaccines can take considerable time in European countries. Reasons might be found in the regulatory framework, decision-making processes or the assessment of vaccines by evaluating bodies. The aim of this study was to determine whether some decision-making processes can explain between-country differences in the time to population access to new vaccination programs.

Languages

  • English

Publication year

2013

Journal

Vaccine

Volume

31

Issue

27

Countries

WHO Regions

Was this useful?
Log in to vote